BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12892299)

  • 1. Association between diabetes mellitus, hypothyroidism or hyperadrenocorticism, and atherosclerosis in dogs.
    Hess RS; Kass PH; Van Winkle TJ
    J Vet Intern Med; 2003; 17(4):489-94. PubMed ID: 12892299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gall bladder mucoceles and their association with endocrinopathies in dogs: a retrospective case-control study.
    Mesich ML; Mayhew PD; Paek M; Holt DE; Brown DC
    J Small Anim Pract; 2009 Dec; 50(12):630-5. PubMed ID: 19954439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus, hyperadrenocorticism, and hypothyroidism in a dog.
    Hess RS; Ward CR
    J Am Anim Hosp Assoc; 1998; 34(3):204-7. PubMed ID: 9590447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Hypertriglyceridemia as a Mediator Between Endocrine Diseases and Pancreatitis in Dogs.
    Kim H; Kang JH; Heo TY; Kang BT; Kim G; Chang D; Na KJ; Yang MP
    J Am Anim Hosp Assoc; 2019; 55(2):92-100. PubMed ID: 30776262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of risk factors for fatal acute pancreatitis in dogs.
    Hess RS; Kass PH; Shofer FS; Van Winkle TJ; Washabau RJ
    J Am Vet Med Assoc; 1999 Jan; 214(1):46-51. PubMed ID: 9887939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between hyperadrenocorticism and development of calcium-containing uroliths in dogs with urolithiasis.
    Hess RS; Kass PH; Ward CR
    J Am Vet Med Assoc; 1998 Jun; 212(12):1889-91. PubMed ID: 9638187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of urinary tract infection in 42 dogs with hyperadrenocorticism or diabetes mellitus or both.
    Forrester SD; Troy GC; Dalton MN; Huffman JW; Holtzman G
    J Vet Intern Med; 1999; 13(6):557-60. PubMed ID: 10587255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of adrenal and thyroid gland dysfunction in dogs with ultrasonographic diagnosis of gallbladder mucocele formation.
    Aicher KM; Cullen JM; Seiler GS; Lunn KF; Mathews KG; Gookin JL
    PLoS One; 2019; 14(2):e0212638. PubMed ID: 30811473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced tear production in three canine endocrinopathies.
    Williams DL; Pierce V; Mellor P; Heath MF
    J Small Anim Pract; 2007 May; 48(5):252-6. PubMed ID: 17425694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent hyperadrenocorticism and diabetes mellitus in dogs.
    Miceli DD; Pignataro OP; Castillo VA
    Res Vet Sci; 2017 Dec; 115():425-431. PubMed ID: 28759861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of hyperadrenocorticism among 210,824 dogs attending primary-care veterinary practices in the UK from 2009 to 2014.
    O'Neill DG; Scudder C; Faire JM; Church DB; McGreevy PD; Thomson PC; Brodbelt DC
    J Small Anim Pract; 2016 Jul; 57(7):365-73. PubMed ID: 27279104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of renal vascular resistance in dogs with diabetes mellitus and hyperadrenocorticism.
    Novellas R; de Gopegui RR; Espada Y
    Vet Rec; 2008 Nov; 163(20):592-6. PubMed ID: 19011245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopenia and other radiographic signs in canine hyperadrenocorticism.
    Schwarz T; Störk CK; Mellor D; Sullivan M
    J Small Anim Pract; 2000 Nov; 41(11):491-5. PubMed ID: 11105787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine hyperadrenocorticism associations with signalment, selected comorbidities and mortality within North American veterinary teaching hospitals.
    Hoffman JM; Lourenço BN; Promislow DEL; Creevy KE
    J Small Anim Pract; 2018 Nov; 59(11):681-690. PubMed ID: 30039567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications and concurrent disease associated with canine hyperadrenocorticism.
    Nichols R
    Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):309-20. PubMed ID: 9076910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of massive hepatocellular carcinoma in dogs: A 4-year retrospective study.
    Leela-Arporn R; Ohta H; Nagata N; Sasaoka K; Tamura M; Dermlim A; Nisa K; Morishita K; Sasaki N; Nakamura K; Takagi S; Hosoya K; Takiguchi M
    Vet J; 2019 Jun; 248():74-78. PubMed ID: 31113567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of refractory demodicosis and transient papules with a single dose of fluralaner in a dog with uncontrolled severe endocrine disease.
    Morita T; Momota Y; Mori A; Oda H; Ike K; Sako T
    J Vet Med Sci; 2018 Apr; 80(4):672-675. PubMed ID: 29515061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytoma and hyperadrenocorticism in dogs: six cases (1982-1992).
    von Dehn BJ; Nelson RW; Feldman EC; Griffey SM
    J Am Vet Med Assoc; 1995 Aug; 207(3):322-4. PubMed ID: 7628933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary evaluation of the circulating leptin/adiponectin ratio in dogs with pituitary-dependent hyperadrenocorticism and concurrent diabetes mellitus.
    Kim H; Kang JH; Jung DI; Kang BT; Chang D; Yang MP
    Domest Anim Endocrinol; 2021 Jan; 74():106506. PubMed ID: 32920447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.